Erythromycylamine (Standard)
Erythromycylamine (Standard) is the analytical standard of Erythromycylamine (HY-W055872). This product is intended for research and analytical applications. Erythromycylamine is a macrolide antibiotic. Erythromycylamine has antibacterial activity against most Gram-positive cocci and M. catarrhalis.
For research use only. We do not sell to patients.
- Purity : 95%
- CAS No.: 26116-56-3
- Formula: C37H70N2O12
- Molecular Weight:734.96
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Purity & Documentation
-
Help & FAQs
-
HY-W055872
ErythromycylamineMacrolide Antibiotic -
HY-B0643
DirithromycinAntibiotic -
HY-100593
SpiramycinAntibiotic -
HY-B0435
RoxithromycinBacterial Inhibitor -
HY-B0435R
Roxithromycin (Standard)Bacterial Inhibitor -
HY-B0643R
Dirithromycin (Standard)Antibiotic -
HY-16487
TemafloxacinAntibacterial Agent -
HY-16487R
Temafloxacin (Standard)Antibacterial Agent
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 26116-56-3
-
Molecular Weight 734.96
-
Formula C37H70N2O12
-
SMILES
C[C@@H]([C@@H]([C@H](C(O[C@@H]([C@@](O)([C@@H]([C@H]([C@H]([C@@H](C[C@]1(O)C)C)N)C)O)C)CC)=O)C)O[C@H]2C[C@](C)([C@H]([C@@H](O2)C)O)OC)[C@H]1O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Naik S, et al. In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex. Antimicrob Agents Chemother. 1989 Sep;33(9):1614-6. [Content Brief]
[2]. Fernandes CJ, et al. Multi-centre collaborative study for the in vitro evaluation of new macrolides dirithromycin and erythromycylamine. Australian Group for Antimicrobial Resistance (AGAR). Pathology. 1995 Jan;27(1):74-8. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Erythromycylamine (Standard) Related Classifications
HY-W055872R Related Classifications
Powered by Bioz